drug

Amantadine Hydrochloride, USP

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by David C. Henderson, MD
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation
NCT00975611Phase 4Terminated

KOLs & investigators

1
David J. Miklowitz, Ph.D.KOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
David C. Henderson, MD
company
trial
Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation
PHASE4
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Hyperprolactinemia
indication
Psychotic Disorders
indication
KOL
David J. Miklowitz, Ph.D.
KOL score 5
person